Surveillance: Clinical Trials

5 trials of Surveillance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 recruiting. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Unknown 2, Recruiting 1

Follow Surveillance: new trials by email Literature Review of Surveillance trials Research Report on Surveillance

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Adjuvant Therapy, Comprehensive Geriatric Assessment, Computed Tomography - Cutaneous Melanoma
Phase 3RecruitingECOG-ACRIN Cancer Research Group4282026-04-172026-09-24
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission
AOP2014 / Pegylated-Proline-interferon alpha-2b, Surveillance - Chronic Myeloid Leukemia in Remission
Phase 3CompletedPhilipps University Marburg2142017-05-042023-03-31
Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index
Imatinib, Surveillance - Gastrointestinal Stromal Tumor
Phase 3UnknownAssistance Publique Hopitaux De Marseille802015-10-012015-10-15
A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
Chemotherapy, Surveillance - Transitional Cell Carcinoma of Ureter
Phase 3UnknownInstitute of Cancer Research, United Kingdom2612012-05-012020-05-04
Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Adjuvant chemotherapy by Fotemustin, Intensive surveillance - Uveal Melanoma
Phase 3CompletedInstitut Curie3022009-06-232022-08-31

Conditions studied

Gastrointestinal Stromal Tumors (1)  ·  Melanoma (1)  ·  Uveal Melanoma (1)

Sponsors

Assistance Publique Hopitaux De Marseille (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Institut Curie (1)  ·  Institute of Cancer Research, United Kingdom (1)  ·  Philipps University Marburg (1)

Countries

France (2)  ·  Germany (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Andreas Burchert, Prof. Dr. (1)  ·  Dr Alison Birtle (1)  ·  Franck E Nicoloni, MD, PhD (1)  ·  Yana Najjar (1)

Results publications

PMID 32145825, PMID 38350047

NIH funding

2014 (1), 2016 (1), U10CA180820 (1)